Answer
Oritavancin diphosphate can cause serious hypersensitivity reactions, including anaphylaxis and anaphylactic shock; an acute hypersensitivity reaction during infusion requires immediate discontinuation and appropriate supportive care.
Sources for this answer
- Tenkasi 400 mg powder for concentrate for solution for infusionA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked